RE:New presentation on the website if interested The investor presentation has a general new look.
Much more focused.
Specifically notes Roche as collaborator with pending phase 3, alternatively the MBc coterapy TBD.
missing?
No more discussion of Incyte trial or any CAR- t oppotunities.
Future business, which was previously given a broad view of partnerships, licensing etc, now not discussed at all.
The San Diego office still listed under contacts.
Clinically a lot cleaner than previous. Shorter & to the point.
it does say panc phase 3 will start mid 2024.
and MBc phase 3 guidance will be updated also first half of this year as well.
missing?
Details of any business deal to fund the trials?
THAT, is what everyone is waiting for.
and.......yes....clarification of WTF is going on with USA office & footprint.
As I have said, too many times: an answer must come ASAP
My opinion a total buyout is the best overall option.
tick, tick, tick,